Table 1 Clinical characteristics of the AD patient. PMD: post mortem delay, ApoE: Apolipoprotein E
From: Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer’s disease
iTRAQ Label used | Age (Years) | Gender | BRAAK | Amyloid | PMD | ApoE | Diagnosis | Region |
|---|---|---|---|---|---|---|---|---|
114 | 67.0 ± 3.0 | Female | 1.0 ± 1.0 | A | 5.7 ± 0.3 | 32.5 ± 0.5 | Non-demented control | medial frontal gyrus |
115 | 68.0 ± 2.0 | Female | 6.0 ± 0.0 | C | 5.2 ± 0.0 | 38 ± 5.0 | Alzheimer’s disease | medial frontal gyrus |
116 | 84.0 ± 3.2 | Female | 1.6 ± 0.8 | B | 6.3 ± 2.4 | 32.5 ± 0.5 | Non-demented control | medial frontal gyrus |
117 | 83.8 ± 3.5 | Female | 5.4 ± 4.9 | C | 6.0 ± 1.5 | 37 ± 4.9 | Alzheimer’s disease | medial frontal gyrus |